The unique information deciphered from the METAssay™ platform and engineered cells were further validated by studying pure tumor cells, isolated from primary tumors of patients.These cells were run across the complete METAssay™ platform, thereby generating a patient-centric dataset, which was then fed into a machine learning algorithm.